glp-1 etfs New Year's Resolutions: Lose Weight & Allocate to Inside the GLP-1 Boom: ETF

President Donald Trump signed an executive order Saturday that he said "directs the FDA to expedite their review of certain psychedelics already designated as breakthrough therapy drugs." "The executive order I'm signing, we're actually signing the executive order today, is really a moment," Trump said

Pancreas 2021

doi: 10.1152/ajpendo.00004.2009

but at a High Price GLP-1 medications like Ozempic and Wegovy are known for suppressing appetite and aiding weight loss

Drug companies are cashing in while they can Novo Nordisk, the Danish creator of Ozempic and Wegovy, made $4.8 billion from the drugs in the third quarter of 2023 alone, boosting the economy in Denmark and leading to lower interest rates for ordinary Danes